Cargando…

Gender Trends in Psychotropic Medication Use in Autism

Autism is a neurodevelopmental condition that includes differences in social communication and restrictive, repetitive behavior. Its diagnosis is far more common in men than women. Therefore, a female phenotype of autism might not concern caregivers or be detected early by clinical assessments. Give...

Descripción completa

Detalles Bibliográficos
Autores principales: Huber, Christopher R, Fanaro, Zachary, Soti, Varun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245521/
https://www.ncbi.nlm.nih.gov/pubmed/35800200
http://dx.doi.org/10.7759/cureus.26447
_version_ 1784738756736057344
author Huber, Christopher R
Fanaro, Zachary
Soti, Varun
author_facet Huber, Christopher R
Fanaro, Zachary
Soti, Varun
author_sort Huber, Christopher R
collection PubMed
description Autism is a neurodevelopmental condition that includes differences in social communication and restrictive, repetitive behavior. Its diagnosis is far more common in men than women. Therefore, a female phenotype of autism might not concern caregivers or be detected early by clinical assessments. Given that medications address problematic behaviors rather than autism, different problems associated with autism necessitate other treatments. We reviewed existing literature on gender differences in psychotropic drug usage in autism patients and found that antidepressants, anticonvulsants, and mood stabilizers were more common in females, while stimulants and antipsychotics were predominant in males. This review highlights that autistic men and women receive different pharmacologic agents, likely attributable to gender-specific trends in presenting problematic behaviors.
format Online
Article
Text
id pubmed-9245521
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-92455212022-07-06 Gender Trends in Psychotropic Medication Use in Autism Huber, Christopher R Fanaro, Zachary Soti, Varun Cureus Neurology Autism is a neurodevelopmental condition that includes differences in social communication and restrictive, repetitive behavior. Its diagnosis is far more common in men than women. Therefore, a female phenotype of autism might not concern caregivers or be detected early by clinical assessments. Given that medications address problematic behaviors rather than autism, different problems associated with autism necessitate other treatments. We reviewed existing literature on gender differences in psychotropic drug usage in autism patients and found that antidepressants, anticonvulsants, and mood stabilizers were more common in females, while stimulants and antipsychotics were predominant in males. This review highlights that autistic men and women receive different pharmacologic agents, likely attributable to gender-specific trends in presenting problematic behaviors. Cureus 2022-06-30 /pmc/articles/PMC9245521/ /pubmed/35800200 http://dx.doi.org/10.7759/cureus.26447 Text en Copyright © 2022, Huber et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Neurology
Huber, Christopher R
Fanaro, Zachary
Soti, Varun
Gender Trends in Psychotropic Medication Use in Autism
title Gender Trends in Psychotropic Medication Use in Autism
title_full Gender Trends in Psychotropic Medication Use in Autism
title_fullStr Gender Trends in Psychotropic Medication Use in Autism
title_full_unstemmed Gender Trends in Psychotropic Medication Use in Autism
title_short Gender Trends in Psychotropic Medication Use in Autism
title_sort gender trends in psychotropic medication use in autism
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245521/
https://www.ncbi.nlm.nih.gov/pubmed/35800200
http://dx.doi.org/10.7759/cureus.26447
work_keys_str_mv AT huberchristopherr gendertrendsinpsychotropicmedicationuseinautism
AT fanarozachary gendertrendsinpsychotropicmedicationuseinautism
AT sotivarun gendertrendsinpsychotropicmedicationuseinautism